Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabazitaxel in relapsed locally advanced or metastatic carcinoma of the penis (phase II)
2014-002336-14Phase 2Completed
- Sponsor
- University Hospitals Bristol and Weston NHS Foundation Trust
- Start
- Sep 2014
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cabazitaxel in penile cancer and penile intraepithelial neoplasia (PeIN), sponsored by University Hospitals Bristol and Weston NHS Foundation Trust. Primary endpoint: Objective response rate. Started Sep 2014; status: completed.
02
Drugs
cabazitaxel
03
Conditions
penile cancerpenile intraepithelial neoplasia (PeIN)
Beyond the preview
Go deeper on 2014-002336-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002336-14.